Steelhead Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,600
Closed -$721K 42
2022
Q3
$721K Buy
+3,600
New +$721K 0.05% 42